123 related articles for article (PubMed ID: 18006845)
1. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA
Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845
[TBL] [Abstract][Full Text] [Related]
2. Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.
Seo Y; Yan T; Schupp JE; Colussi V; Taylor KL; Kinsella TJ
Clin Cancer Res; 2004 Nov; 10(22):7520-8. PubMed ID: 15569982
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the effects of iododeoxyuridine and ionising radiation treatment on the cell cycle dynamics of DNA mismatch repair deficient human colorectal cancer cells.
Gurkan-Cavusoglu E; Schupp JE; Kinsella TJ; Loparo KA
IET Syst Biol; 2013 Aug; 7(4):114-24. PubMed ID: 23919954
[TBL] [Abstract][Full Text] [Related]
4. The interaction between two radiosensitizers: 5-iododeoxyuridine and caffeine.
Seo Y; Yan T; Schupp JE; Yamane K; Radivoyevitch T; Kinsella TJ
Cancer Res; 2006 Jan; 66(1):490-8. PubMed ID: 16397265
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
Yamane K; Schupp JE; Kinsella TJ
Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data.
Martin LM; Marples B; Coffey M; Lawler M; Lynch TH; Hollywood D; Marignol L
Cancer Treat Rev; 2010 Nov; 36(7):518-27. PubMed ID: 20413225
[TBL] [Abstract][Full Text] [Related]
8. Integration of Principles of Systems Biology and Radiation Biology: Toward Development of in silico Models to Optimize IUdR-Mediated Radiosensitization of DNA Mismatch Repair Deficient (Damage Tolerant) Human Cancers.
Kinsella TJ; Gurkan-Cavusoglu E; Du W; Loparo KA
Front Oncol; 2011; 1():20. PubMed ID: 22649757
[TBL] [Abstract][Full Text] [Related]
9. Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro.
Xu Y; Jagtap MR; Garland T; Ying J; McGarry RC; Mendonca MS; McLennan G
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):73-8. PubMed ID: 17296707
[TBL] [Abstract][Full Text] [Related]
10. The cell cycle and DNA mismatch repair.
Schroering AG; Edelbrock MA; Richards TJ; Williams KJ
Exp Cell Res; 2007 Jan; 313(2):292-304. PubMed ID: 17157834
[TBL] [Abstract][Full Text] [Related]
11. Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence.
Yan T; Seo Y; Schupp JE; Zeng X; Desai AB; Kinsella TJ
Mol Cancer Ther; 2006 Apr; 5(4):893-902. PubMed ID: 16648559
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA mismatch repair for radiosensitization.
Berry SE; Kinsella TJ
Semin Radiat Oncol; 2001 Oct; 11(4):300-15. PubMed ID: 11677655
[TBL] [Abstract][Full Text] [Related]
13. Effects of DNA-targeted ionizing radiation produced by 5-[125I]iodo-2'-deoxyuridine on global gene expression in primary human cells.
Sokolov MV; Neumann RD; Panyutin IG
BMC Genomics; 2007 Jun; 8():192. PubMed ID: 17594496
[TBL] [Abstract][Full Text] [Related]
14. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
Schneiderman MH; Schneiderman GS
J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
[TBL] [Abstract][Full Text] [Related]
15. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
16. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
17. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
Kinsella TJ
Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
[TBL] [Abstract][Full Text] [Related]
19. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle phase dependent role of DNA polymerase beta in DNA repair and survival after ionizing radiation.
Vermeulen C; Verwijs-Janssen M; Begg AC; Vens C
Radiother Oncol; 2008 Mar; 86(3):391-8. PubMed ID: 18237797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
